Accéder directement au contenu Accéder directement à la navigation
Article dans une revue

Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far

Abstract :

Angiogenesis, the formation of new blood vessels, is an essential component of glioblastoma (GB) progression. The development of angiogenesis inhibitor therapy, including treatments targeting vascular endothelial growth factor (VEGF) in particular, raised new hopes for the treatment of GB, but no Phase III clinical trial to date has reported survival benefits relative to standard treatment. There are several possible reasons for this limited efficacy, including VEGF-independent angiogenesis, induction of tumor invasion, and inefficient antiangiogenic factor delivery to the tumor. Efforts have been made to overcome these limitations by identifying new angiogenesis inhibitors that target angiogenesis through different mechanisms of action without inducing tumor invasion, and through the development of viral and nonviral delivery methods to improve antiangiogenic activity. Herein, we describe the nonviral methods, including convection-enhanced delivery devices, implantable polymer devices, nanocarriers, and cellular vehicles, to deliver antiangiogenic factors. We focus on those evaluated in intracranial (orthotopic) animal models of GB, the most relevant models of this disease, as they reproduce the clinical scenario of tumor progression and therapy response encountered in GB patients.

Type de document :
Article dans une revue
Liste complète des métadonnées

Littérature citée [126 références]  Voir  Masquer  Télécharger

https://hal.univ-angers.fr/hal-02616075
Contributeur : Okina Université d'Angers <>
Soumis le : dimanche 24 mai 2020 - 04:34:40
Dernière modification le : vendredi 19 juin 2020 - 03:09:17

Fichier

clavreul_2019_nanocarriers_and...
Accord explicite pour ce dépôt

Licence


Distributed under a Creative Commons Paternité - Pas d'utilisation commerciale 4.0 International License

Identifiants

Citation

Anne Clavreul, Milad Pourbaghi-Masouleh, Emilie Roger, Philippe Menei. Nanocarriers and nonviral methods for delivering antiangiogenic factors for glioblastoma therapy: the story so far. International Journal of Nanomedicine, Dove Medical Press, 2019, 14, pp.2497-2513. ⟨10.2147/IJN.S194858⟩. ⟨hal-02616075⟩

Partager

Métriques

Consultations de la notice

42

Téléchargements de fichiers

76